Insider filing
Traded Dec 4, 2025 · filed 5 days later
Not classified as an open-market trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 12, 2025 · Filed Nov 14, 2025
A Repligen director sold $580K of Repligen shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$579,556
Shares × reported transaction price
15 days after results of Oct 28, 2025, 104 days before results of Feb 24, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $158.01 on Nov 12, 2025, 45% above its 52-week low and 9% below its high, after an 8% rise over the previous 30 trading days
52-week range $108.89 (Apr 8, 2025) to $174.24 (Jan 28, 2025), 75% of the way up, from 250 adjusted closes. 30 trading days earlier: $145.81 on Oct 1, 2025. Describes the past only, not a forecast
RSI 61, 18% above its 200-day average, 13% above its 50-day average, 9% below the 52-week high, 20-day volatility 45% a year, against the S&P 500: +3 points over 1 month, +19 points over 3 months, +7 points over 6 months
From the adjusted closes up to Nov 12, 2025. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +6.7% | −1.9% | +8.6% |
| 30 days | +5.4% | +1.3% | +4.1% |
| 90 days | −13.0% | +1.4% | −14.3% |
| 180 days | −29.8% | +10.5% | −40.2% |
| 365 days | +6.8% | +10.1% | −3.3% |
Past results only. Not a forecast.
Insider filing
Traded Dec 4, 2025 · filed 5 days later
Not classified as an open-market trade.
Olivier Loeillot (Chief Executive Officer) sold ~$1.2M of Repligen
Planned saleCongress
Traded Oct 30, 2025 · disclosed 22 days laterSpouse
Held by the filer's spouse per the disclosure.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.